NIH-funded research NIH-funded research

Pulmonary Immunopathology Core for lung disease research

Official title: Pulmonary Immunopathology Core (PIP)

Funded at Louisiana State Univ A&m Col Baton Rouge · NIH-11382844 · Data updated 2026-11-12

A dedicated core at LSU helps researchers study how lung diseases develop, using mice and immune tools to advance understanding of acute lung injury and related conditions.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionLouisiana State Univ A&m Col Baton Rouge
NIH-funded
Lab location1 site (Baton Rouge, United States)
Project startJanuary 2, 2019
Project endJune 30, 2029
Funding year2026
Award (this year)$253,676
NIH project number5P20GM130555-08
Project IDNIH-11382844 on NIH RePORTER

Who could benefit from this research

Could help

Patients with acute lung injury, acute pulmonary injury, or severe inflammatory responses in the lungs could benefit from advances driven by this research.

Less likely to help

This core does not directly enroll patients; its work is foundational research used to improve future patient care.

What this research studies

This grant supports the Pulmonary Immunopathology Core (PIPC) within LSU’s Center for Lung Biology and Disease to provide equipment, facilities, and training for investigators studying lung immunopathology. It focuses on comprehensive immunopathological assessments in mice and other model systems to understand life-threatening respiratory diseases caused by infections and environmental exposures. The core has already enabled collaboration, produced high-impact publications, and supported junior investigators, researchers, and students through lectures and workshops. In Phase II, the core will continue to offer expert resources and methods to characterize immune responses and pathology in lung injury models.

Why it matters

Potential benefit: If successful, this core could accelerate discoveries that translate into better prevention and treatment of acute lung injury and related lung diseases.

How similar studies have gone: Previous phases showed productive collaborations and high-impact publications, indicating the model’s effectiveness.

Where this research is happening

  • Louisiana State Univ A&m Col Baton Rouge
    Baton Rouge, United States
    Active

Researchers

  • Principal investigator: Jelesijevic, Tomislav — Louisiana State Univ A&m Col Baton Rouge
  • Study coordinator: Jelesijevic, Tomislav

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.